Michèle Ollier

General Partner
Medicxi Ventures

Medicxi Ventures is a new venture capital firm comprising all of the existing life sciences portfolio companies, funds and team from Index Ventures. Michele currently serves on the board of directors of Ipsen Pharmaceuticals, and also sits on the investment committees of the accelerator and technology transfer companies of Paris-Saclay and France-Nord.

Check out the incredible speaker line-up to see who will be joining Michèle.

Download The Latest Agenda

Day 1

Friday, February 9th, 2018

16:25 INTERACTIVE ROUNDTABLES: Exploring what market influences are driving sector-specific PE investment opportunities

How are current economic trends impacting these sectors and investment potential?
What are the returns seen in each sector now and predicted for 2017?
How have valuations changed over the last year and how has this impacted investment behaviour?
Where and how are these opportunities to be found?

1. Technology - Reynir Indahl, Partner, Summa Equity

2. Healthcare/Biotech - Michèle Ollier, General Partner, Medicxi Ventures

3. Energy - Richard Nourse, Managing Partner, Greencoat Capital

4. Finance - Lindsey McMurray, Managing Partner, Pollen Street Capital